PL2035457T3 - Nośnik szczepionki - Google Patents

Nośnik szczepionki

Info

Publication number
PL2035457T3
PL2035457T3 PL07718492T PL07718492T PL2035457T3 PL 2035457 T3 PL2035457 T3 PL 2035457T3 PL 07718492 T PL07718492 T PL 07718492T PL 07718492 T PL07718492 T PL 07718492T PL 2035457 T3 PL2035457 T3 PL 2035457T3
Authority
PL
Poland
Prior art keywords
vaccine carrier
vaccine
carrier
Prior art date
Application number
PL07718492T
Other languages
English (en)
Inventor
Rudolf Valenta
Margarete Focke-Tejkl
Birgit Linhart
Susanne Vrtala
Peter Valent
Renate Reininger
Susanne Spitzauer
Ines Swoboda
Hage Marianne Van
Hans Grönlund
Johanna Tinhofer
Kerstin Westritschnig
Theresia Popow-Kraupp
Original Assignee
Biomay Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomay Ag filed Critical Biomay Ag
Publication of PL2035457T3 publication Critical patent/PL2035457T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07718492T 2006-06-09 2007-06-11 Nośnik szczepionki PL2035457T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0099406A AT503690A1 (de) 2006-06-09 2006-06-09 Hypoallergene moleküle
EP07718492.7A EP2035457B1 (en) 2006-06-09 2007-06-11 Vaccine carrier
PCT/AT2007/000281 WO2007140505A2 (en) 2006-06-09 2007-06-11 Vaccine carrier

Publications (1)

Publication Number Publication Date
PL2035457T3 true PL2035457T3 (pl) 2015-10-30

Family

ID=38650124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07718492T PL2035457T3 (pl) 2006-06-09 2007-06-11 Nośnik szczepionki

Country Status (14)

Country Link
US (2) US9296828B2 (pl)
EP (2) EP2035457B1 (pl)
JP (3) JP5399895B2 (pl)
CN (3) CN103319602B (pl)
AT (1) AT503690A1 (pl)
AU (1) AU2007257308B2 (pl)
BR (1) BR122019004393B1 (pl)
CA (1) CA2657971C (pl)
DK (2) DK2035457T3 (pl)
ES (2) ES2698525T3 (pl)
PL (1) PL2035457T3 (pl)
PT (1) PT2035457E (pl)
RU (1) RU2486206C2 (pl)
WO (1) WO2007140505A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022154A2 (en) 2007-08-15 2009-02-19 Circassia Limited Peptide with multiple epitopes
PT2153841E (pt) * 2008-08-15 2012-03-21 Circassia Ltd Vacina compreendendo péptidos amb a 1 para utilização no tratamento de alergia a ambrósia
WO2010076583A1 (en) * 2008-12-30 2010-07-08 Kaw Yan Chua A variant of mite allergen and uses thereof
CO6260019A1 (es) * 2009-01-30 2011-03-22 Fundacion Universidad Del Norte Metodo y composicion inmunoquimica para la deteccion de alergenos de acaros usando anticuerpos policlonales igy
AU2013202362B2 (en) * 2009-02-05 2015-09-17 Circassia Limited Grass Peptides for Vaccine
MX2011008179A (es) * 2009-02-05 2011-09-09 Circassia Ltd Peptidos para vacuna.
EP2316481A1 (en) * 2009-10-30 2011-05-04 Biomay Ag Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
PT2717910T (pt) * 2011-06-09 2019-05-22 Biomay Ag Proteínas de fusão transportadoras de péptido como vacinas para alergia
JP5897120B2 (ja) * 2011-06-27 2016-03-30 アネルギ エスアー ブタクサ花粉アレルギーの治療のための連続する重複ペプチド
EP2543725A1 (en) 2011-07-08 2013-01-09 Biomay Ag Polysaccharide lyases
JO3820B1 (ar) * 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
GB201209868D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Alternaria peptides
EP2727934B1 (en) 2012-09-20 2016-06-15 Universidad de Cartagena Fusion proteins with representation of different allergens: vaccine proposal for mite allergies
JP2014231500A (ja) * 2013-05-29 2014-12-11 元晴 植原 シラカンバ花粉症の免疫療法に用いるペプチド混合物
EP3564671B1 (en) 2013-08-23 2021-09-29 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
WO2017004561A1 (en) * 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
EP4717709A2 (en) 2016-12-22 2026-04-01 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
EP3569612A1 (en) * 2018-05-18 2019-11-20 Biomay Ag Treatment and prevention of house dust mite allergies
RU2761431C9 (ru) 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8821077D0 (en) 1988-09-08 1988-10-05 Wellcome Found Peptides
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
IL103456A (en) * 1991-10-16 2006-06-11 Merck Patent Gmbh Isolated peptides having t-cell stimulating activity
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
AT401937B (de) * 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
AU680820B2 (en) * 1993-04-14 1997-08-14 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides(house dust mite)
AU717187B2 (en) * 1994-04-14 2000-03-16 Merck Patent Gmbh Pharmaceutical peptide formulations for treatment of dust mite allergy
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
US6572859B1 (en) * 1999-10-29 2003-06-03 Pharmacia Diagnostics Ab Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
US20030166518A1 (en) * 2000-01-13 2003-09-04 Beardslee Thomas A. Method for allergen characterization
DE60137230D1 (de) * 2000-07-06 2009-02-12 Univ Georgetown Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
ES2209563B1 (es) 2000-07-28 2005-10-01 Universidad Complutense De Madrid Produccion en la levadurapipchia pastoris y sistema de purificacion del alergeno recombinante de olea europaea ole e 1 para uso en diagnosis y tratamiento de alergias.
ES2317955T3 (es) 2000-11-16 2009-05-01 Alk-Abello A/S Alergenos mutantes.
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
WO2003072601A1 (de) 2002-02-27 2003-09-04 Merck Patent Gmbh VERFAHREN ZUR HERSTELLUNG VON HYPOALLERGENEM BIRKENPOLLENHAUPTALLERGEN rBet v 1
AU2003251604A1 (en) * 2002-06-26 2004-01-19 F. C. Thomas Allnutt Viruses and virus-like particles for multiple antigen and target display
DK1523329T3 (da) 2002-07-05 2013-10-14 Folia Biotech Inc Viruspartikeladjuvant
EP1440979B1 (en) 2003-01-21 2005-10-19 BIOMAY Produktions- und Handels- Aktiengesellschaft Process for the preparation of hypoallergenic mosaic proteins
GB0308988D0 (en) * 2003-04-17 2003-05-28 Univ Singapore Molecule
PL2272863T3 (pl) * 2003-06-04 2013-03-29 Merck Patent Gmbh Pochodne poa p 5 o zredukowanej alergeniczności i zakonserwowanej reaktywności komórek t
US20050053615A1 (en) * 2003-07-16 2005-03-10 Best Elaine A. Variants of mite group 1 allergens for the treatment of house dust mite allergy
DE10351471A1 (de) * 2003-11-04 2005-06-09 Ursula Prof. Dr. Wiedermann-Schmidt Polyvalente Allergievakzine
US20050214321A1 (en) * 2003-12-01 2005-09-29 Dow Global Technologies Inc. Recombinant icosahedral virus like particle production in pseudomonads
ITRM20040103A1 (it) 2004-02-27 2004-05-27 Consiglio Nazionale Ricerche Proteine di fusione comprendenti allergeni della famiglia delle ns-ltps, loro usi e composizioni farmaceutiche che le comprendono.
JP2007528727A (ja) * 2004-02-27 2007-10-18 ザ　ダウ　ケミカル　カンパニー 植物細胞における高効率ペプチド生産
US20060088549A1 (en) * 2004-07-08 2006-04-27 Arnold Gail F Chimeric virus vaccine
DE102004035337A1 (de) 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
MX2007003171A (es) * 2004-09-21 2007-05-23 Cytos Biotechnology Ag Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico.
AT501101B1 (de) 2004-12-02 2008-01-15 Biomay Ag Protein-allergen-derivat
MX2007011160A (es) * 2005-03-18 2007-11-13 Cytos Biotechnology Ag Conjugados de alergenos de gato y usos de los mismos.
DE602006014846D1 (de) * 2005-09-15 2010-07-22 Alk Abello As Verfahren zur quantifizierung von allergenen

Also Published As

Publication number Publication date
US20090324501A1 (en) 2009-12-31
JP5399895B2 (ja) 2014-01-29
AU2007257308B2 (en) 2013-06-06
CN103319602B (zh) 2016-09-07
RU2008152045A (ru) 2010-07-20
RU2486206C2 (ru) 2013-06-27
ES2698525T3 (es) 2019-02-05
EP2035457A2 (en) 2009-03-18
US9296828B2 (en) 2016-03-29
BR122019004393B1 (pt) 2023-10-17
AT503690A1 (de) 2007-12-15
PT2035457E (pt) 2015-07-28
JP2014064573A (ja) 2014-04-17
EP2924047A1 (en) 2015-09-30
CN103319601A (zh) 2013-09-25
EP2035457B1 (en) 2015-04-01
DK2924047T3 (en) 2018-12-03
CA2657971A1 (en) 2007-12-13
WO2007140505A3 (en) 2008-03-20
CN101466738A (zh) 2009-06-24
EP2924047B1 (en) 2018-08-22
AU2007257308A1 (en) 2007-12-13
US20160257722A1 (en) 2016-09-08
WO2007140505A2 (en) 2007-12-13
JP2014087341A (ja) 2014-05-15
JP2009539354A (ja) 2009-11-19
CN103319602A (zh) 2013-09-25
DK2035457T3 (en) 2015-06-15
CA2657971C (en) 2018-01-23
ES2541311T3 (es) 2015-07-17
BRPI0712421A2 (pt) 2012-06-19

Similar Documents

Publication Publication Date Title
PL2035457T3 (pl) Nośnik szczepionki
GB0607088D0 (en) Vaccine
GB0711858D0 (en) Vaccine
GB0616306D0 (en) Vaccines
ZA200902155B (en) IPV-DPT vaccine
GB0700135D0 (en) Vaccine
GB0710538D0 (en) Vaccine
ZA200901592B (en) Vaccine
GB0614460D0 (en) Vaccines
GB0724772D0 (en) Carrier
GB0702229D0 (en) Carrier
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0625593D0 (en) Vaccine
GB0622348D0 (en) Retaining means
GB0617450D0 (en) Liverstock carriers
TWI346426B (en) Carrier
GB0619822D0 (en) Vaccine
GB0620816D0 (en) vaccine
GB0620337D0 (en) Vaccine
GB0606256D0 (en) Anti-atheroma vaccine
GB0619820D0 (en) Vaccine
GB0614254D0 (en) Vaccine
GB0608962D0 (en) Vaccine
GB0607087D0 (en) Vaccine
GB0620336D0 (en) Vaccine